Report ID: 10352283 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Cellbag Bioreactor Chambers Market Highlights Over 2020 - 2030
The global cellbag bioreactor chambers market is estimated to garner a revenue of USD 5124.6 Million by the end of 2030 by growing at a CAGR of 12.7% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market registered a revenue of USD 1554.0 Million. The growth of the market can primarily be attributed to the growing research in the field of healthcare and the rising trends of cell culture in the field of cellular and molecular biology. Cell culture is an emerging field of biological science and has recently gained significant attention of the researchers, backed by the increasing number of research projects carried out in this area. With the increasing number of research projects related to cell culture, the demand for cellbag bioreactor chambers is also projected to increase, and in turn, drive the market growth in the coming years.
CLICK TO DOWNLOAD SAMPLE REPORT
One of the major factors that is driving the attention of researchers in the field of molecular biology is the growing prevalence of chronic diseases, especially cancer. According to the statistics by the World Health Organization (WHO), the most common causes of cancer in the year 2020 was breast, lung, colon & rectum cancers, followed by prostate, skin (non-melanoma), and stomach cancers with 2.26 Million cases, 2.21 Million cases, 1.93 Million cases, 1.41 Million cases, 1.20 Million cases, and 1.09 Million cases respectively. Cell culture is an important process used in the process of replacing cancer cells. Growing awareness for stem cell therapies worldwide, and the rising adoption of this therapy for treating spinal cord injuries, Parkinson’s disease, diabetes, Alzheimer’s disease, and stroke among others, are also expected to create numerous opportunities for market growth. Moreover, increasing cell-based research along with the growing technological advancements in the field of devising advanced medical and healthcare devices, including bioreactors, are also expected to accelerate the market growth in the coming years.
Global Cellbag Bioreactor Chambers Market Regional Synopsis
Regionally, the global cellbag bioreactor chambers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 2269.2 Million by the end of 2030, up from a revenue of USD 723.1 Million in the year 2020. The growth of the market in the region can primarily be attributed to the growing prevalence of chronic diseases in the region, primarily in the United States, along with the elevating count of oncology-related cell therapy clinical trials registered in the region. According to the statistics by the Centers for Disease Control and Prevention (CDC), out of 10 adults, 6 adults in the United States have a chronic disease. The market in Europe, on the other hand, is projected to garner the second-largest revenue of USD 1258.9 Million by the end of 2030, up from a revenue of USD 376.1 Million in the year 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherland, and the Rest of Europe. Out of these, the market in Germany is anticipated to gain the largest revenue of USD 240.8 Million by the end of 2030, up from a revenue of USD 68.8 Million in the year 2020.
Growth Drivers and Challenges Impacting the Growth of the Global Cellbag Bioreactor Chambers Market
Growth Drivers
-
Growing Technological Advancements in the Field of Medical and Healthcare Devices
-
Rising Cell-Based Research and Development Activities
Challenges
-
High Cost of the Equipment
-
Regulatory Concerns with the Use of Bioreactors
Global Cellbag Bioreactor Chambers Market Segmentation Synopsis
The global cellbag bioreactor chambers market is segmented by material into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others. Out of these, the polypropylene segment is anticipated to garner the largest revenue of USD 1265.8 Million by the end of 2030, up from a revenue of USD 372.0 Million in the year 2020. By component, the market is segmented into bioclear films, barbed ports, MCP connectors, silicone tubing, internal perfusion filters, tubing adaptors, and others. Out of these, the tubing adaptors segment is projected to display the second-largest revenue of USD 786.8 Million by the end of 2030, up from a revenue of USD 223.6 Million in the year 2020. By application, the market is segmented into antibody production, virus production, insect cell production, vaccines, CGMP production, and others. Out of these, the vaccines segment is anticipated to garner the second-largest revenue of USD 1284.7 Million by the end of 2030, up from a revenue of USD 376.8 Million in the year 2020. By scale, the market is segmented into <50L, 50-100L, and >100L. Out of these, the <50L segment is projected to display the largest revenue of USD 2857.4 Million by the end of 2030. Moreover, by end-user, the market is segmented into pharmaceutical companies, biopharmaceutical companies, drug discovery companies, and research institutes. Out of these, the biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 1730.0 Million by the end of 2030.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cellbag bioreactor chambers market that are included in our report are Thermo Fisher Scientific, Avantor, Inc., Global Life Sciences Solutions USA LLC (Cytiva), Sartorius AG, Pall Corporation, Celltainer Biotech BV, Adolf Kuhner AG, Merck KGaA, TERUMO BCT, INC., and others.
Latest Developments in the Global Cellbag Bioreactor Chambers Market:
-
October 21st, 2021: TERUMO BCT, INC. announced that it has opened its manufacturing facility in Costa Rica that is aimed at producing medical devices that collect and separate blood and cells for use in cell collection and processing organizations, hospitals, and therapeutic apheresis clinics among others. The new 20,000 square meter plant has been built with an investment amount of USD 60 Million.
-
July 26th, 2017: Pall Corporation announced that it has introduced the mPath bioreactor control system that is aimed at delivering accurate measurement and control of single-use process development-scale bioprocesses.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
1. Introduction
1.1. Market Definition
1.2.Market Segmentation
2. Assumptions
3. Research Methodology
3.1.Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary – Global Cell Therapy Technologies Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Regulatory and Standards Landscape
9. Industry Risk Analysis
10. Pricing Analysis of Cell therapy Technologies Market
11. Value Chain Analysis
12.Impact of COVID-19 on the Cell Therapy Technologies Market
13.Market Share Analysis Based on Therapy
14.Competitive Positioning
15. Competitive Landscape
15.1. Market Share Analysis, 2020
15.2. Competitive Benchmarking
15.3. Company Profiles
15.3.1. Lonza Group Ltd.
15.3.2. Sartorius AG
15.3.3. Danaher Corporation
15.3.4. Becton
15.3.5. Dickinson and Company
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. Avantor, Inc.
15.3.8. Eppendorf SE
15.3.9. Miltenyi Biotec B.V. & Co. KG
16.KOL Mapping
17. Bioreactors Market Analysis w.r.t. Product, Region, and Year
18.Future Forecast of the Manufactures and Startup Companies
19.Global Cell Therapy Technologies Market 2020-2030
19.1. Market Overview
19.2. By Value (USD Million)
20. Global Cell Therapy Technologies Market-Segmentation analysis 2020-2030
20.1. Product
20.1.1. Consumables, 2020-2030F (USD Million)
20.1.2. System & Software, 2020-2030F (USD Million)
20.1.3. Equipment, 2020-2030F (USD Million)
20.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
20.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
20.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
20.2. Process
20.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
20.2.2. Cell Processing, 2020-2030F (USD Million)
20.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
20.3. Cell Type
20.3.1. T-Cells, 2020-2030F (USD Million)
20.3.2. Stem Cells, 2020-2030F (USD Million)
20.3.3. Other Cells, 2020-2030F (USD Million)
20.4. End-User
20.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
20.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
20.4.3. Cell banks, 2020-2030F (USD Million)
20.4.4. Research institutes, 2020-2030F (USD Million)
20.4.5. Other End-Users, 2020-2030F (USD Million)
20.5. Region
20.5.1. North America, 2020-2030F (USD Million)
20.5.2. Europe, 2020-2030F (USD Million)
20.5.3. Asia Pacific, 2020-2030F (USD Million)
20.5.4. Latin America, 2020-2030F (USD Million)
20.5.5. Middle East & Africa, 2020-2030F (USD Million)
21.North America Therapy Technologies Market-Segmentation analysis 2020-2030
21.1. Product
21.1.1. Consumables, 2020-2030F (USD Million)
21.1.2. System & Software, 2020-2030F (USD Million)
21.1.3. Equipment, 2020-2030F (USD Million)
21.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
21.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
21.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
21.2. Process
21.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
21.2.2. Cell Processing, 2020-2030F (USD Million)
21.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
21.3. Cell Type
21.3.1. T-Cells, 2020-2030F (USD Million)
21.3.2. Stem Cells, 2020-2030F (USD Million)
21.3.3. Other Cells, 2020-2030F (USD Million)
21.4. End-User
21.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
21.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
21.4.3. Cell banks, 2020-2030F (USD Million)
21.4.4. Research institutes, 2020-2030F (USD Million)
21.4.5. Other End-Users, 2020-2030F (USD Million)
21.5. Country
21.5.1. United States, 2020-2030F (USD Million)
21.5.2. Canada, 2020-2030F (USD Million)
22. Europe Therapy Technologies Market-Segmentation analysis 2020-2030
22.1. Product
22.2. Process
22.3. Cell-Type
22.4. End-User
22.5. Country
22.5.1. Germany
22.5.2. United Kingdom
22.5.3. France
22.5.4. Italy
22.5.5. Spain
22.5.6. Russia
22.5.7. Netherland
22.5.8. Rest of Europe
23. Asia Pacific Technologies Market-Segmentation analysis 2020-2030
23.1. Product
23.2. Process
23.3. Cell-Type
23.4. End-User
23.5. Country
23.5.1. China
23.5.2. India
23.5.3. Japan
23.5.4. South Korea
23.5.5. Australia
23.5.6. Singapore
23.5.7. Rest of APAC
24. Latin America Technologies Market-Segmentation analysis 2020-2030
24.1. Product
24.2. Process
24.3. Cell-Type
24.4. End-User
24.5. Country
24.5.1. Brazil
24.5.2. Argentina
24.5.3. Mexico
24.5.4. Rest of LATAM
25. Middle East & Africa Technologies Market-Segmentation analysis 2020-2030
25.1. Product
25.2. Process
25.3. Cell-Type
25.4. End-User
25.5. Country
25.5.1. GCC
25.5.2. Israel
25.5.3. South Africa
25.5.4. Rest of MEA
Frequently Asked Question
The market is segmented by material, component, application, scale, end-user, and by region.
The polypropylene segment is anticipated to garner the largest revenue of USD 1265.8 Million by the end of 2030 and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10352283 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
